Together, these results show that the IFN-γ-expressing, TNF-α-expressing, and IL-17-expressing CD4+ Tcm cells were significantly decreased in the blood of the NSCLC patients. The gene discussed is IL17A; the disease is non-small cell lung carcinoma.